VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ A concentration of LDL-cholesterol above 100 mg /  │ A concentration of LDL-cholesterol above 100 mg /  │     100 │
│ dl, in the month prior to inclusion                │ dl, in the month prior to inclusion                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ An apnea-hypopnea index between 5-30 h-1           │ An apnea-hypopnea index between 5-30 h-1           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Apnea-hypopnea index of less than 5 h-1 or greater │ Apnea-hypopnea index of less than 5 h-1 or greater │     100 │
│ than 30 h-1                                        │ than 30 h-1                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Predominance of central apneas and hypopneas,      │ Predominance of central apneas and hypopneas,      │     100 │
│ defined as more than 25% of all respiratory events │ defined as more than 25% of all respiratory events │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Professional drivers, risk profession or           │ Professional drivers, risk profession or           │     100 │
│ respiratory failure (according to criteria of the  │ respiratory failure (according to criteria of the  │         │
│ clinical pathway for diagnosis and treatment of    │ clinical pathway for diagnosis and treatment of    │         │
│ sleep-disordered breathing)                        │ sleep-disordered breathing)                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Prior treatment with CPAP                          │ Prior treatment with CPAP                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Morbid obesity (BMI\> 40 kg / m2)                  │ Morbid obesity (BMI> 40 kg / m2)                   │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosis of dyslipidemia: The existence of a      │ Diagnosis of dyslipidemia: The existence of a      │      99 │
│ previous clinical diagnostic of dyslipidemia       │ previous clinical diagnostic of dyslipidemia       │         │
│ associated with lipid-lowering therapy. It is also │ associated with lipid-lowering therapy. It is also │         │
│ considered patients who have an altered            │ considered patients who have an altered            │         │
│ analytical, using the following cutoffs: total     │ analytical, using the following cutoffs: total     │         │
│ cholesterol ≥ 200 mg / dl, triglycerides ≥ 180 mg  │ cholesterol = 200 mg / dl, triglycerides = 180 mg  │         │
│ / dl, HDL-cholesterol ≤ 40 mg / dl or LDL-         │ / dl, HDL-cholesterol = 40 mg / dl or LDL-         │         │
│ cholesterol ≥ 150 mg / dl. Lipid-lowering          │ cholesterol = 150 mg / dl. Lipid-lowering          │         │
│ treatment and diet, stable in the last month       │ treatment and diet, stable in the last month       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Very excessive daytime sleepiness (Epworth         │ Very excessive daytime sleepiness (Epworth         │      99 │
│ Sleepiness Scale\> 18)                             │ Sleepiness Scale> 18)                              │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 75 Years │ Apnea-hypopnea index of less than 5 h-1 or greater │      29 │
│                                   │ than 30 h-1                                        │         │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 35 Years │ Apnea-hypopnea index of less than 5 h-1 or greater │      32 │
│                                   │ than 30 h-1                                        │         │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 96
Average Levenshtein Ratio of individual lines: 87.0
OverAll Ratio: 91.5
